opensansad/lok-sabha-qa huggingface dataset:
Lok Sabha Question No. 3422 (UNSTARRED), answered on 2021-12-17
Subject: High Court Bench in Western Uttar Pradesh
Ministry: LAW AND JUSTICE
Asked by: Haji Fazlur Rehman

## GOVERNMENT OF INDIA

## MINISTRY OF LAW AND JUSTICE DEPARTMENT OF JUSTICE

## LOK SABHA

## UNSTARRED QUESTION NO. †3422

## TO BE ANSWERED ON FRIDAY, THE 17.12.2021

## High Court Bench in Western Uttar Pradesh

## †3422. SHRI HAJI FAZLUR REHMAN:

## Will the Minister of LAW AND JUSTICE be pleased to state:

- (a) whether the Government proposes to setup aHigh Court Bench in Western Uttar Pradesh;
- (b) if so, the details thereof;
- (c) if not, the reasons therefor;
- (d) whether the Government has invited thedelegation of lawyers of Western Uttar  Pradesh  for  talksin  this  regard  and  sought  suggestions  from  them; and
- (e) if so, the details thereof?

## ANSWER

## MINISTER OF LAW AND JUSTICE

## (SHRI KIREN RIJIJU)

(a) to (c) : High Court Benches are established in accordance with the recommendations  made  by  the  Jaswant  Singh  Commission  and  judgment pronounced  by  the  Apex  Court  in  W.P.(C)  No.379  of  2000  and  after    due consideration of a complete proposal from the State Government which has to provide necessary expenditure and infrastructural facilities and the Chief Justice of theconcerned High Court who  is required to look after the day to dayadministration of the High Court. The proposal to be complete should also have the consent of the Governor of the concerned State. At  present,  no  complete  proposal  regarding  setting  up  of  Benchof Allahabad High Court in Western Uttar Pradesh is pending with the Government. No  Sir,  However,  A  combined  delegation  of  Advocates  of  Bar Associations of Meerut, Moradabad, GautamBudh Nagar and Muzaffarnagarmet November, 2021 and requested for a High

(d) to (e) : Minister of Law and Justice on 27 th Court Bench in Western Uttar Pradesh.

*****
Lok Sabha Question No. 3417 (UNSTARRED), answered on 2021-12-17
Subject: AYUSH Doctors
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: Ganesh Singh

## GOVERNMENT OF INDIA MINISTRY OF AYUSH

## LOK SABHA UNSTARRED QUESTION NO.-3417 ANSWERED ON 17/12/2021

## AYUSH DOCTORS

## 3417.   SHRI GANESH  SINGH:

Will the Minister of AYUSH be pleased to state:

- (a) whether the Government is aware that some States have given permission to AYUSH doctors to prescribe allopathic medicines;
- (b) if so, the details thereof;
- (c) whether  the  Union  Government  is  considering  to  authorise  the  AYUSH  doctors  to prescribe allopathic medicines by providing a one year bridge course; and
- (d) if so, the details thereof?

## ANSWER

## THE MINISTER OF AYUSH (SHRI SARBANANDA SONOWAL)

- (a) to  (b): Public  Health  is  a  State  subject  and  giving  permission  to  AYUSH  Doctors  to prescribe  Allopathic  Medicines  in  the  States  comes  under  the  purview  of  respective State/ UT Governments.

The  right  of  persons  to  practice  ISM  (Indian  System  of  Medicine)  practitioner  is protected under Section 34 of NCISM  Act, 2020 (Details are available on https://egazette.nic.in/WriteReadData/2020/221863.pdf). However, a few State Governments have permitted Ayurvedic Doctors to prescribe certain essential Allopathic Medicines.

- (c)  &  (d): The Ministry of Ayush is not considering authorizing the AYUSH Doctors to prescribe Allopathic Medicines by providing a one-year bridge course.

*****
Lok Sabha Question No. 3413 (UNSTARRED), answered on 2021-12-17
Subject: CGHS Wellness Centre in Manipur
Ministry: HEALTH AND FAMILY WELFARE
Asked by: Lorho S. Pfoze

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA UNSTARRED QUESTION NO. 3413 TO BE ANSWERED ON 17 TH DECEMBER, 2021

## CGHS WELLNESS CENTRE IN MANIPUR

## 3413.  SHRI LORHO S. PFOZE:

## Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a)  whether the Government proposes to set up additional CGHS Centre in the hilly areas of Manipur to cater to the Central Government employees and pensioners there;
- (b)  if so, the details thereof; and
- (c)  if not, whether the Government would like to consider setting up such centre as there is only one CGHS Centre in the State which is not very accessible for the people living in hilly areas?

## ANSWER THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE

(DR. BHARATI PRAVIN PAWAR)

- (a)  to  (c)  There  is  no  such  proposal  to  set  up  additional  CGHS  Wellness  Centre  (s)  in Manipur. Setting up of new CGHS Wellness Centre (s) is considered as per extant norms and subject to availability of resources including creation of posts of medical officers and other staff with the approval of Ministry of Finance.

******
Lok Sabha Question No. 3410 (UNSTARRED), answered on 2021-12-17
Subject: Access to COVID-19 Data Collated by ICMR
Ministry: HEALTH AND FAMILY WELFARE
Asked by: Behanan Benny

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH RESEARCH

## LOK SABHA UNSTARRED QUESTION NO. 3410 TO BE ANSWERED ON 17 th  DECEMBER, 2021

## ACCESS TO COVID-19 DATA COLLATED BY ICMR

## 3410. SHRI BENNY BEHANAN:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a)  whether  the  Government  has  taken  cognizance  of  the  request  made  by  scientists, appointed for tracking/ developing new prediction model for COVID-19 pandemic, for wider access  to  the  granular  COVID-19  testing  data  collated  by  the  Indian  Council  of  Medical Research (ICMR);
- (b)  if  so,  the  details  thereof  and  the  reasons  for  such  data  not  being  made  available  to  the above scientists;
- (c)  the  steps  taken  by  the  Government  to  make  the  ICMR  database  accessible  to  the scientists;
- (d) whether the data is available in real-time; and
- (e)  if  not,  the  average  time  taken  between  requesting  access  to  the  data  and  access  being granted?

## ANSWER THE MINISTER OF STATE FOR HEALTH AND FAMILY WELFARE DR. BHARATI PRAVIN PAWAR

(a) to (e): All testing data collated by the Indian Council of Medical Research (ICMR) is accessible  to  National  Informatics  Centre  (NIC),  Ministry  of  Health  and  Family  Welfare, Govt of India, National Centre for Disease Control (NCDC), National Disaster Management Authority (NDMA), National Health Authority (NHA), and States/UTs Government. ICMR has a well-defined protocol for 'Access to COVID-19 Health and Scientific Data'. As per the protocol  an  Independent  Data  Access  Committee  objectively/systematically  reviews  data access request pertaining to COVID-19 data repository. Data is available on real time basis.

*****
Lok Sabha Question No. 3407 (UNSTARRED), answered on 2021-12-17
Subject: Proposal for Setting up of Pharma Park in Haryana
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Dharambir Singh

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 3407

TO BE ANSWERED ON THE 17 th  December, 2021

Proposal for Setting up of Pharma Park in Haryana

## 3407. SHRI DHARAMBIR SINGH:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a)  whether  world  class  Bulk  Drugs  and  Medical  Devices  Parks  (Pharma  Park)  have  been established in States including Haryana and if so, the details thereof;
- (b) whether the Government has received any proposal from the State Government of Haryana for setting up Pharma Park in several district of the State;
- (c) if so, the details thereof, district-wise; and
- (d) the name of the places where Pharma Parks have been established recently along with the cost incurred in this regard?

## ANSWER

## MINISTER IN THE MINISTRY OF CHEMICALS & FERTILIZERS (Dr. MANSUKH MANDAVIYA)

(a)  to  (d):  Under  the  scheme  for  'Promotion  of  Bulk  Drug  Parks',  Department  of Pharmaceuticals has received proposals seeking financial assistance from 13 States including Haryana wherein the proposed site for bulk drug park is located in Hisar District. The scheme provides for grant-in-aid support to 3 Bulk drug Parks.

Under the scheme 'Promotion of Medical Devices Parks', Department of Pharmaceuticals  has  received  proposals  seeking  financial  assistance  from  16  States/Union Territories including Haryana. After evaluation of the proposals, the Government vide letter dated 24.09.2021 has granted in-principle approval financial assistance  for  common infrastructure facilities for 4 medical device parks i.e. Himachal Pradesh, Tamil Nadu, Madhya Pradesh and Uttar Pradesh.

xxxxx
Lok Sabha Question No. 3406 (UNSTARRED), answered on 2021-12-17
Subject: Survey of Sero Positivity
Ministry: HEALTH AND FAMILY WELFARE
Asked by: Thirumaa Valavan Thol

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH RESEARCH

LOK SABHA UNSTARRED QUESTION NO. 3406

## TO BE ANSWERED ON 17 th  DECEMBER, 2021

## SURVEY OF SERO POSITIVITY

## 3406. SHRI THIRUMAAVALAVAN THOL:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a) whether the Government has any information about the survey of Sero-positivity, Sero-prevalence
- for Corona virus/COVID-19, taken by the States/UT or private entities;
- (b) if so, the details thereof; and
- (c) if not, whether the Government has any proposal to conduct such a survey?

## THE MINISTER OF STATE FOR HEALTH AND FAMILY WELFARE

## ANSWER DR. BHARATI PRAVIN PAWAR

(a) to (c): Findings of the national serosurvey of SARS-CoV-2 infection in India were corroborated into  published  articles  from  time  to  time  by  the  Indian  Council  of  Medical  Research  (ICMR)&  its Institutes.  Listed  in  the  Table  below  are  the  details  of  the  respective  publications  reporting State/District-wise national serosurvey data from January 2020-January 2021.

|   SI No . | Title of the article                                                                                                                                  | Journal Name                                | Web links                                                                |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|--------------------------------------------------------------------------|
|         1 | Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID- 19, January 22 - April 30, 2020 | Indian Journal of Medical Research          | https://www.ncbi.nlm.ni h.gov/pmc/articles/PMC 7530445/                  |
|         2 | Prevalence of SARSCoV-2 infection in India: Findings from the national serosurvey, May-June 2020                                                      | Indian Journal of Medical Research          | https://pubmed.ncbi.nlm. nih.gov/32952144/                               |
|         3 | SARS-CoV-2 antibody seroprevalence in India,August-September,2020:findings from the second nationwide household serosurvey                            | The Lancet Global Health                    | https://www.sciencedirec t.com/science/article/pii/ S2214109X20305441    |
|         4 | SARS-CoV-2 Sero prevalence among the general population and healthcare workers in India. December 2020-January 2021                                   | International Journal of Infectious Disease | https://www.ijidonline.c om/article/S1201- 9712(21)00442- 2/fulltext#%20 |

Besides, serosurvey conducted by National Center for Disease Control (NCDC)on people above 5 years of age in Delhi in July 2020 shows 23.48 % seroprevalence.

*****
Lok Sabha Question No. 3405 (UNSTARRED), answered on 2021-12-17
Subject: Treatment for Hepatitis B
Ministry: HEALTH AND FAMILY WELFARE
Asked by: Anil Firojiya, Tapir Gao

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE

## DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA UNSTARRED QUESTION NO. 3405 TO BE ANSWERED ON 17 TH  DECEMBER, 2021

## TREATMENT FOR HEPATITIS B

## 3405. SHRI ANIL FIROJIYA: SHRI TAPIR GAO:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a) whether the Government has taken any measures for ensuring protection from fatal disease like Hepatitis B;
- (b) if so, the details thereof;
- (c) whether any treatment is available for a person infected with the said fatal disease; and
- (d) if so, the details thereof?

## ANSWER THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE

## (DR. BHARATI PRAVIN PAWAR)

(a) to (d): National Viral Hepatitis Control Program (NVHCP) was launched in 2018. In order to prevent Hepatitis B, screening is done during Ante-Natal Care (ANC) of pregnant women for Hepatitis B  as  well.  It  is  a  vaccine  preventable  disease  and  the  program,  in  coordination  with  immunization division, is ensuring Hepatitis B birth dose vaccine and Hepatitis B Immunoglobulin to babies born to Hepatitis B positive mothers. Hepatitis B  vaccine is also part of Universal Immunization Programme. The program envisages prevention through awareness generation, and management of viral hepatitis 'B' by providing free diagnosis and drugs across the board.  Treatment of Hepatitis-B is available free of cost. States/UTs  are  provided  support  under  NHM  based  on  the  proposals  received  from  them  for  treatment  of Hepatitis B for those who require the same.
Lok Sabha Question No. 3404 (UNSTARRED), answered on 2021-12-17
Subject: Bulk Drug Park in Telangana
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Venkatesh Netha Borlakunta, Kavitha Malothu, Dayakar Pasunoori, Gaddam Ranjith Reddy

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 3404

TO BE ANSWERED ON THE 17 th  December, 2021

## Bulk Drug Park in Telangana

3404.   SHRI VENKATESH NETHA BORLAKUNTA: SHRIMATI KAVITHA MALOTHU: SHRI PASUNOORI DAYAKAR: DR. G. RANJITH REDDY:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) the status of implementation of the scheme 'Promotion of Bulk Drug Parks' in the country, State/ UT-wise;
- (b) the details of criteria set for selection of a particular place for setting up Bulk Drug Park;
- (c) whether Telangana is known as pharmacy of the country and if so, the details thereof;
- (d) whether the Government proposes to set up Bulk Drug Park under the Bulk Drug Parks Scheme in Telangana; and
- (e) if so, the details thereof?

## ANSWER

## MINISTER IN THE MINISTRY OF CHEMICALS & FERTILIZERS (Dr. MANSUKH MANDAVIYA)

(a) to (e): The scheme 'Promotion of Bulk Drug Parks' provides for grant-in-aid support for creation of Common Infrastructure Facilities to 3 bulk drug parks. The selection criteria is laid down in  the  detailed  guidelines  of  the  scheme,  which  are  available  on  the  website  of  the Department of Pharmaceuticals i.e. http://pharmaceuticals.gov.in. Under this scheme, Department of Pharmaceuticals has received proposals from 13 states, including Telangana. The proposals are under evaluation.

*****
Lok Sabha Question No. 3403 (UNSTARRED), answered on 2021-12-17
Subject: Special Call Centre
Ministry: WOMEN AND CHILD DEVELOPMENT
Asked by: Balubhau (Alias Suresh Narayan) Dhanorkar

## GOVERNMENT OF INDIA MINISTRY OF WOMEN AND CHILD DEVELOPMENT

## LOK SABHA

UNSTARRED QUESTION NO. 3403 TO BE ANSWERED ON 17.12.2021

## SPECIAL CALL CENTRE

## 3403. SHRI BALUBHAU ALIAS SURESH NARAYAN DHANORKAR

Will the Minister of WOMEN AND CHILD DEVELOPMENT be pleased to state:

- (a) whether the National Commission for Women has forwarded any proposal to the Government for starting a Special Call Centre for redressal of the grievances of women;
- (b) if so, the salient features of the above proposal;
- (c) whether  the  Government  has  assessed  all  the  aspects  related  to  opening  of Special Call Centre for women;
- (d) if so, whether any steps have been taken by the Government for implementation of the aforesaid proposal; and
- (e) if so, the details thereof?

## ANSWER

## MINISTER OF WOMEN AND CHILD DEVELOPMENT (SHRIMATI SMRITI ZUBIN IRANI)

(a) & (b) .   There is no proposal received from National Commission for Women (NCW) for starting a Special Call Centre for redressal of the grievances of women.

The Commission has not moved any proposal to Government for starting a Special Call Centre for redressal of the grievance of Women.  However, the National Commission for  Women  has  launched  dedicated  24x7  Helpline  number  7827170170  in  the Commission on 27.07.2021 with a view to address the grievances of Women in distress seeking support and information round the clock.

NCW has  also  engaged  Clinical  Psychologists  for  counseling  of  Complainants.   For management  of  complaints,  a  software  has  been  developed  through  Digital  India Corporation  (an  undertaking  of  Ministry  of  Electronic  and  Information  Technology (MEiTY)).   Till  14/12/2021  total  37,321  number  of  calls  has  been  received  through Helpline.

- (c) to (e).  Does not arise

******
Lok Sabha Question No. 3402 (UNSTARRED), answered on 2021-12-17
Subject: Fertilizer Supply to Tea Industry
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Pallab Lochan Das

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF FERTILIZERS

## LOK SABHA

## UNSTARRED QUESTION NO. 3402 TO BE ANSWERED ON: 17.12.2021

Fertilizer Supply to Tea Industry

3402:

SHRI PALLAB LOCHAN DAS:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) the total  Production of Urea by Brahmaputra Fertilizer  Corporation Limited; Namrup per annum; Valley
- (c) whether it is fact that the Government recently provided Rs. 100 crore package for the revival of Unit Il and Unit IIl of Brahmaputra Fertilizer Corporation Limited, Namrup; Valley
- (b) whether it is a fact that Brahmaputra Fertilizer  Corporation Limited, Namrup is fertilizer supplier to the tea industry and agricultural sector in the entire north-eastern region and if the details thereof; Valley
- if so, the details thereof; and
- (e) whether it is also a fact that the Government proposes to meet with all the stakeholders of Unit IV of Brahmaputra Valley Fertilizer Corporation Limited, Namrup for its revival?

## ANSWER

## MINISTER OF HEALTH & FAMILY WELFARE AND CHEMICALS & FERTILIZERS (DR\_MANSUKH MANDAVIYA)

- The total production of urea by Brahmaputra Fertilizer Corporation Limited, Namrup per annum is 2.87 , 1.56 & 1.32 LMT for the year 2018-19 2019-20 and 2020-21 respectively: Valley
- (b): BVFCL in addition to the other suppliers) supplies to the North-Eastern region meet the monthly requirement as projected by Department of Agriculture & Farmers Welfare DA&FW.
- (c) & (d): The Govt: of India approved the financial grant-in-aid of Rs.100 Cr to BVFCL to sustain operation of the urea manufacturing units. The funds have been transferred to BVFCL.
- (e) A high level meeting was held on 11.11.2021 with various stakeholders on setting up of Namrup-IV urea plant at BVFCL (Assam):
Lok Sabha Question No. 3401 (UNSTARRED), answered on 2021-12-17
Subject: Constitution of 21st Law Commission
Ministry: LAW AND JUSTICE
Asked by: Adoor Prakash

## GOVERNMENT OF INDIA MINISTRY OF LAW AND JUSTICE DEPARTMENT OF LEGAL AFFAIRS

****

## LOK SABHA

## UNSTARRED QUESTION NO. 3401

## TO BE ANSWERED ON FRIDAY, THE 17 TH  DECEMBER, 2021

## Constitution of 21 st Law Commission

## 3401.  ADV. ADOOR PRAKASH

Will the Minister of LAW AND JUSTICE be pleased to state:

- (a) whether the term of 21 st Law Commission has expired, if so, the details thereof;
- (b) whether the Union Cabinet has approved the formation of the 22 nd Law Commission, if so, the details thereof;
- (c) the reasons for delay in the formation of 22 nd Law Commission; and
- (d) the details of reports of the Department Related to Parliamentary Standing Committee on  Personnel,  Public  Grievances  and  Law  and  Justice  which  are  still  pending  for examination of the Law Commission of India?

## ANSWER

## MINISTER OF LAW AND JUSTICE (SHRI KIREN RIJIJU)

****

- (a): Yes,Sir.The term of 21 st Law Commission of India endedon the 31 st August, 2018.
- (b) & (c): The  Cabinet  has  approved  for  the  constitution  of  22 nd Law  Commission  of India  for  a  term  of  three  years w.e.f. 21 st February,  2020  with  the  composition  as  detailed below:
- (i) a full-time Chairperson;
- (ii) four full-time Members (including Member-Secretary);
- (iii) Secretary, Department of Legal Affairs as ex officio Member;
- (iv) Secretary, Legislative Department as ex officio Member; and
- (v) not more than five part-time Members.

The appointment of Chairperson, Full-time and Part-time Members is envisaged for the formation of the 22 nd Law Commission of India.

- (d) The 21 st Law Commission of India, on a reference from the Legislative Department examined  the  issues  for  holding  simultaneous  elections  to  the  Lok  Sabha  and  the  State Legislative Assemblies as contained in the 79 th report of the Department-Related Parliamentary Standing Committee on Personnel, Public Grievances and Law and Justice.  A draft report has been placed in the public domain (on the Website of the Law Commission) for wider discussion.

*****
Lok Sabha Question No. 3399 (UNSTARRED), answered on 2021-12-17
Subject: Drugs for Treatment of Cancer
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Sukhbir Singh Jaunapuria, Ranjanben Dhananjay Bhatt

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION NO. 3399 TO BE ANSWERED ON THE 17 th  December, 2021

## Drugs for Treatment of Cancer

## †3399. SHRI SUKHBIR SINGH JAUNAPURIA: SHRIMATI RANJANBEN DHANANJAY BHATT:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a)  whether  the  Government  has  taken  any  concrete  steps  to  enable  the  Central  Public  Sector Undertakings to manufacture drugs for the treatment of cancer and if so, the details thereof;
- (b) the details of  the  prices  of  drugs  manufactured  by  the  CPSUs  vis-à-vis  the  drugs manufactured by private pharmaceutical companies;
- (c) whether the Government proposes to reduce the price of drugs required for the treatment of cancer;
- (d) if so, the details thereof and the steps taken in this direction so far; and
- (e) if not, the reasons therefor?

## ANSWER

## MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (Dr. MANSUKH MANDAVIYA)

(a)  to  (e)  :  There  are  five  pharma  Public  Sector  Undertakings  (PSUs)  under  the  aegis  of  the Department  of  Pharmaceuticals,  namely  (i) Bengal  Chemicals  &  Pharmaceuticals  Limited (BCPL),  (ii) Hindustan Antibiotics Limited  (HAL),  (iii) Indian  Drugs  &  Pharmaceuticals Limited (IDPL), (iv) Karnataka Antibiotics & Pharmaceutical Limited (KAPL) and (v) Rajasthan Drugs & Pharmaceuticals Limited (RDPL). But, none of the pharma PSUs are manufacturing any drugs for the treatment of cancer.

However,  National Pharmaceutical Pricing Authority (NPPA),  an attached office of Department  of  Pharmaceuticals,  which  is  mandated  for  price  regulation  of  scheduled drugs, has fixed the ceiling prices of 86 anti-cancer scheduled formulations under the National List  of  Essential  Medicines  (NLEM),  2015.  Further,  NPPA  has  also  put  a  cap  of  30%  Trade Margin on 42 selected non-scheduled anti-cancer medicines on pilot basis under 'Trade Margin Rationalization' approach. Under this approach, the Maximum Retail Price (MRP) of 526 brands of anti-cancer medicines have been reduced by upto 90%.

*****